London-based personalized supplements start-up Bioniq has raised $15m in Series B financing, which it says will finance further disruption of the global dietary supplements market.
Led by principal investors HV Capital and Unbound, the “oversubscribed” funding round will finance “product development including global laboratory network integrations, market, operational, and human resources expansion in the US and the Middle East, and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?